Ann Conkle
May 3, 2012
Cipla lowers generic price of Bayer's Nexavar
Indian drugmaker Cipla cut the price of its generic version of Bayer's cancer drug Nexavar by 75 percent, nearly two months after India allowed another drugmaker to make a cut-rate version of the drug over Bayer's objections.